Company Number: 14027910

Analysis Date: 2025-07-20 17:28 UTC

1. Risk Rating: MEDIUM
   The company shows signs of limited financial resources with net current liabilities and minimal shareholder funds. However, it remains active, compliant with filing deadlines, and has director support in place mitigating immediate solvency concerns.

2. Key Concerns:

• Negative net current assets at year-end 2024 (-£1,461) indicating a short-term liquidity deficit.
• High current liabilities relative to current assets (£33,673 vs £32,212), which raises concerns about meeting short-term obligations without additional funding or improved cash flows.
• Significant operating lease commitments totaling £66,885 over the next five years, which may strain cash flows if revenue does not grow.

3. Positive Indicators:

• Directors have confirmed they will not seek repayment of amounts owed by the company until financially viable, providing some internal financial flexibility.
• No overdue filings for accounts or confirmation statements, reflecting good regulatory compliance and governance.
• The company is relatively new (incorporated 2022) and operating within a specialist medical practice sector, which may offer growth opportunities.

4. Due Diligence Notes:

• Investigate the nature and timing of trade debtors (£16,306), especially the significant increase from prior year (£3,496), to assess collectability risk.
• Review the company’s cash flow forecasts and revenue trends to understand operational sustainability and ability to meet lease commitments.
• Clarify the details and terms of directors' loans (£2,273 owed to directors), including whether these are interest-bearing and their impact on liquidity.